181. Artificial Intelligence-Enabled ECG Analysis to Predict Incident Heart Failure.
作者: Shaan Khurshid.;Samuel F Friedman.;Shinwan Kany.;Valentina D'Souza.;Athar Roshandelpoor.;Leah B Kosyakovsky.;Mandana Chitsazan.;Jonathan W Cunningham.;Pulkit Singh.;Emily S Lau.;Daniel Pipilas.;Mostafa Al-Alusi.;Joel T Rämö.;James P Pirruccello.;Christopher Reeder.;Jonathan W Waks.;Steven A Lubitz.;Anthony A Philippakis.;Mahnaz Maddah.;Patrick T Ellinor.;Jennifer E Ho.
来源: Circ Heart Fail. 2026年e013927页
ECG-based artificial intelligence may enable efficient prediction of incident heart failure (HF) risk to facilitate preventive efforts. Prior models are proprietary, with modest or inconsistent accuracy. We sought to develop and validate a generalizable and publicly available convolutional neural network to predict incident HF using the 12-lead ECG waveform (ECG-to-HF [ECG2HF]).
182. Invasive Hemodynamic Exercise Response in Hemodynamically Significant Aortic Stenosis With Preserved Left Ventricular Ejection Fraction.
作者: Mulham Ali.;Peter Hartmund Frederiksen.;Jacob Eifer Møller.;Nils Sofus Borg Mogensen.;Alexander Chemnitz.;Amal Haujir.;Mikael Kjær Poulsen.;Kristian Altern Øvrehus.;Philippe Pibarot.;Patricia A Pellikka.;Marie-Annick Clavel.;Jordi Sanchez Dahl.
来源: Circ Heart Fail. 2026年e012809页
Guidelines acknowledge that discordant low-gradient (LG) aortic stenosis (AS) may be severe, but verifying this can be challenging. Right heart catheterization during exercise is considered the gold standard for evaluating ventricular hemodynamics. No invasive studies have compared the hemodynamic response of discordant LG and severe AS during exercise. The aim of this observational study was to describe exercise hemodynamics in patients with asymptomatic discordant AS and left ventricular ejection fraction ≥50%.
183. Mitigating Risk of Kidney Dysfunction After Heart Transplantation and Therapeutic Approaches.
作者: Ersilia M DeFilippis.;Richard K Cheng.;Elena M Donald.;Shannon M Dunlay.;Lorraine S Evangelista.;Forum Kamdar.;Prateeti Khazanie.;Selma F Mohammed.;Ana Rossi.;Harriette G C Van Spall.;Aradhana Verma.;Khadijah Breathett.
来源: Circ Heart Fail. 2026年e013747页
Kidney dysfunction after heart transplantation (HT) is associated with significant morbidity and mortality. Recipient and perioperative factors may all influence the risk of kidney injury. Furthermore, data suggest that the incidence of kidney dysfunction, both acute and chronic, is increasing after the implementation of the United States' 2018 allocation system due to increasing use of temporary mechanical circulatory support and changing recipient characteristics. While data are robust regarding nephroprotective therapies such as renin-angiotensin-aldosterone system inhibition and SGLT2 (sodium-glucose cotransporter 2) inhibitors to minimize the progression of chronic kidney disease in patients with heart failure, data in HT recipients are beginning to emerge. This state-of-the-art review will critically examine the existing literature regarding the epidemiology of kidney dysfunction after HT, mitigation strategies for acute kidney injury and chronic kidney disease, including pharmacotherapeutics, the need for kidney transplantation after HT, and practical next steps for the larger HT community.
185. Correction to: Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Health Care: A Science Advisory From the American Heart Association.
作者: Sneha S Jain.;Shinichi Goto.;Jennifer L Hall.;Sadiya S Khan.;Calum A MacRae.;Cyril Ofori.;Cheryl Pegus.;Michael Pencina.;Eric D Peterson.;Lee H Schwamm.; .
来源: Circulation. 2026年153卷8期e264页 187. Letter by Huang and Fogacci Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".188. Response by Berry et al to Letter Regarding Article, "High-Volume Physical Activity and Clinical Coronary Artery Disease Outcomes: Findings From the Cooper Center Longitudinal Study".
作者: Jarett D Berry.;David Leonard.;Benjamin D Levine.;Laura F DeFina.
来源: Circulation. 2026年153卷8期e113-e114页 189. Polygenic and Monogenic Contributions to Tachycardia-Associated Cardiomyopathy.
作者: Sina Safabakhsh.;Paloma Jordà.;Steffany Grondin.;Ismael Henarejos-Castillo.;Amir Fazeli.;Zachary Laksman.;Jeremy Parker.;Nidal El Yamani.;Nazih Benhenda.;Martin Aguilar.;Katia Dyrda.;Peter G Guerra.;Paul Khairy.;Laurent Macle.;Blandine Mondésert.;Adrian M Petzl.;Léna Rivard.;Denis Roy.;Bernard Thibault.;Jean-Claude Tardif.;Julia Cadrin-Tourigny.;Jason D Roberts.;Alexandre Raymond-Paquin.;Rafik Tadros.
来源: Circulation. 2026年153卷8期607-609页 190. Low-Dose Colchicine Attenuates Clonal Hematopoiesis in COLCOT.
作者: Jean-Claude Tardif.;Lambert Busque.;Steve Geoffroy.;Johanna Sandoval.;Louis-Philippe Lemieux Perreault.;Ian Mongrain.;Marie-France Gagnon.;Diane Valois.;Marie-Josée Gaulin-Marion.;Manuel Buscarlet.;Aldo P Maggioni.;Simon Kouz.;Fausto J Pinto.;Jose Lopez-Sendon.;David D Waters.;Rafael Diaz.;Habib Gamra.;Ghassan S Kiwan.;Colin Berry.;Wolfgang Koenig.;Jean C Grégoire.;Philippe L L'Allier.;Mylène Provencher.;Marie-Claude Guertin.;François Roubille.;Essaïd Oussaïd.;Amina Barhdadi.;Marie-Pierre Dubé.
来源: Circulation. 2026年153卷8期610-612页 191. Distinct Subdivisions of the Cingulo-Insular Region and Their Role in Modulating the Cardiac Sympathetic-Parasympathetic Balance.
作者: Yingxuan Li.;Na Clara Pan.;Cuiping Xu.;Liang Qiao.;Xueyuan Wang.;Wei Shu.;Tao Yu.;Yuping Wang.
来源: Circ Arrhythm Electrophysiol. 2026年19卷3期e013875页
The cingulo-insular region is crucial for modulating cardiac activity. However, the distinct roles of its anatomic subdivisions in modulating sympathetic-parasympathetic balance remain poorly defined. We aimed to explore the distinct contributions of subdivisions within the cingulo-insular region to modulating cardio-autonomic balance.
192. Risk in Women Emerges at Lower Coronary Plaque Burden Than in Men: PROMISE Trial.
作者: Jan M Brendel.;Thomas Mayrhofer.;Júlia Karády.;Márton Kolossváry.;Nóra M Kerkovits.;Isabel L Langenbach.;Matthias Jung.;Michelle D Kelsey.;Marcel C Langenbach.;Neha Pagidipati.;Svati H Shah.;Michael T Lu.;Maros Ferencik.;Pamela S Douglas.;Borek Foldyna.
来源: Circ Cardiovasc Imaging. 2026年19卷3期e019011页
Quantitative coronary plaque measures differ in prognostic value between women and men. It remains unclear whether cardiovascular risk increases proportionally with plaque extent in both sexes. We aimed to compare cardiovascular risk trajectories across quantitative coronary plaque measures in women and men with stable chest pain.
195. PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis.
作者: Antros Louca.;Petur Petursson.;Joakim Sundström.;Henrik Hagström.;Andreas Rück.;Stefan James.;Sasha Koul.;Kristofer Skoglund.;Mohammed Mohammed.;Anders Jeppsson.;Dan Ioanes.;Sebastian Völz.;Anna Myredal.;Oskar Angerås.;Araz Rawshani.;Truls Råmunddal.
来源: Circ Cardiovasc Interv. 2026年e016337页
The optimal management of coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) remains unclear, and evidence supporting routine percutaneous coronary intervention (PCI) beforehand is limited. This study aimed to evaluate whether PCI before TAVR provides clinical benefit compared with conservative management in patients with significant coronary artery disease, using nationwide Swedish registry data.
196. Angiographic Burden of Coronary Atherosclerosis Partially Mediates the Association Between ASCVD Risk Factors and Outcomes.
作者: Noah L Tsao.;Sarah A Abramowitz.;Gabrielle E Shakt.;Renae Judy.;Austin T Hilliard.;Scott M Damrauer.;Themistocles L Assimes.;Shoa L Clarke.;Catherine Tcheandjieu.;Michael G Levin.; .
来源: Circ Genom Precis Med. 2026年e005266页
Coronary artery disease (CAD) is a major contributor to cardiovascular morbidity (including myocardial infarction and heart failure) and mortality. Although the burden of CAD (number and degree of coronary artery stenosis) has been observationally linked to these outcomes, the causal contribution and independence from traditional cardiovascular risk factors have been poorly defined.
197. Left Atrial Strain Predicts Cardiac Outcomes in Moderate Aortic Stenosis.
作者: Minjung Bak.;Sang Yoon Lee.;Sung-Ji Park.;Heayoung Shin.;Jihoon Kim.;Eun Kyoung Kim.;Sung-A Chang.;Sang-Chol Lee.;Seung Woo Park.
来源: Circ Cardiovasc Imaging. 2026年19卷3期e018451页
Moderate aortic stenosis (AS) poses a substantial risk for adverse outcomes, yet its prognostic determinants and cardiac remodeling markers remain underexplored. This study aimed to evaluate prognostic factors, including left atrial strain, and their predictive value for adverse cardiac events in patients with moderate AS.
198. HEV-Targeted Antibody-Drug Conjugate Promotes Long-Term Cardiac Allograft Acceptance.
作者: Yanjia Che.;Yuta Yamamura.;Sungwook Jung.;Gianmarco Sabiu.;Shameer M Kondengadan.;Stephani Edwina Lucia.;Yang Song.;Hayeon Byun.;Xiaofei Li.;Andy J Seelam.;Minako Yamamura.;Yuta Inoue.;Jing Zhao.;Joren C Madsen.;Vivek Kasinath.;Kenji Uchimura.;George C Tsokos.;Pilhan Kim.;Jonathan S Bromberg.;Reza Abdi.
来源: Circulation. 2026年
The entrance of naive T cells into lymph nodes (LNs) is a crucial step for induction of heart transplant acceptance under costimulatory blockade. Specialized blood vessels within the LN known as high endothelial venules (HEVs) mediate this process. HEVs express a key glycoprotein containing 6-sulfo sialyl Lewis X, the binding site for L-selectin on the membrane of naive T cells. The proper formation of this carbohydrate requires sulfation by N-acetylglucosamine 6-O-sulfotransferases, particularly CHST4. Given the critical role of CHST4 in HEVs and transplant immunity, we aimed to develop a first-in-class antibody-drug conjugate (ADC) targeting the CHST4/HEV axis to deliver immunoregulatory molecules to LNs and promote long-term cardiac transplant survival.
199. Peripartum Cardiogenic Shock From Effusive-Constrictive Pericarditis Requiring VA-ECMO and Pericardiectomy.
作者: Revathy Sampath-Kumar.;MaryAnn Villareal-Gonzalez.;Antonio Duran.;Oluwole Fadare.;Mazen Odish.;Demosthenes G Papamatheakis.;Jenny Yang.;Victor Pretorius.;Marcus Anthony Urey.
来源: Circ Heart Fail. 2026年e013056页 200. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
作者: .;Mark A Creager.;Geoffrey D Barnes.;Jay Giri.;Debabrata Mukherjee.;William Schuyler Jones.;Allison E Burnett.;Teresa Carman.;Ana I Casanegra.;Lana A Castellucci.;Sherrell M Clark.;Mary Cushman.;Kerstin de Wit.;Jennifer M Eaves.;Margaret C Fang.;Joshua B Goldberg.;Stanislav Henkin.;Hillary Johnston-Cox.;Sabeeda Kadavath.;Daniella Kadian-Dodov.;William Brent Keeling.;Andrew J P Klein.;Jun Li.;Michael C McDaniel.;Lisa K Moores.;Gregory Piazza.;Karen S Prenger.;Steven C Pugliese.;Mona Ranade.;Rachel P Rosovsky.;Farla Russo.;Eric A Secemsky.;Akhilesh K Sista.;Leben Tefera.;Ido Weinberg.;Lauren M Westafer.;Michael N Young.
来源: Circulation. 2026年153卷12期e977-e1051页
The "2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults" is a de novo guideline that provides comprehensive recommendations for the evaluation, management, and follow-up of adult patients (≥18 years of age) with acute pulmonary embolism (PE). A key feature of this guideline is the introduction of the AHA/ACC Acute Pulmonary Embolism Clinical Categories, which enhance the precision of severity classification, prognosis assessment, and evidence-based therapeutic decision-making.
|